Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

 315.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,252.00
  • 52 Week Low: 315.50
  • Currency: UK Pounds
  • Shares Issued: 3.60m
  • Volume: 0
  • Market Cap: £11.37m
  • RiskGrade: 340

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-24 Interim n/a (2.82) (80.00)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a (1.49) (160.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 n/a (2.10) (200.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (5.11) (280.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (3.99) (200.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 n/a (6.70) (240.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Forecasts data is not available for this company.

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

HEMO Market Data

Currency UK Pounds
Share Price 315.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,252.00
52 Week Low 315.50
Volume 0
Shares Issued 3.60m
Market Cap £11.37m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
42.53% below the market average42.53% below the market average42.53% below the market average42.53% below the market average42.53% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Price Trend
88.44% below the market average88.44% below the market average88.44% below the market average88.44% below the market average88.44% below the market average
75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average75.51% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page